Viral diseases of the Ostrich (Struthio camelus var. domesticus)

The ostrich is an important animal in many livestock industries. A significant threat to this industry is losses from diseases. Newcastle disease is a notifiable, highly contagious viral infection of ostriches. Avian influenza may be transmitted from waterfowl, shorebirds and gulls to ostriches. Borna disease virus is a viral neurotropic infection spread mainly by rodents and felines. Crimean‐Congo hemorrhagic fever is a viral disease transmitted by Hyalomma ticks to humans. Avipoxvirus afflicts ostrich chicks and is transmitted by mosquitoes or by direct contact with a pox lesion. Maintenance of a healthy and profitable enterprise requires the implementation, with assistance from the local veterinary authority, of comprehensive, practical and effective methods of health management and preventative medicine.     

水貂大肠埃希氏菌病的诊治试验

通过对患病水貂进行病理剖检,细菌纯培养,病毒检测,生化鉴定,确定是水貂大肠埃希氏菌病。再应用多种抗生素作药敏试验,筛选出了高度敏感的抗菌药。并对山东省威海地区水貂大肠埃希氏菌病的发生规律进行了探讨。     

重庆市近郊区县鸭传染性浆膜炎病病原分离鉴定及防治

通过对重庆近郊的沙坪坝区、北碚区、九龙坡区、永川市、璧山县、铜梁县的7个养鸭场病死鸭的病原分离,分离到三株细菌,经染色镜检、生化鉴定、动物回归实验,确诊为鸭里氏杆菌。药敏试验结果显示对庆大霉素、青霉素、链霉素、土霉素等高度敏感。在临床上交替使用这些药物,收到较好治疗效果。将分离菌制成灭活苗免疫1周龄的健康鸭,20日龄时用分离菌进行攻毒,平均保护率达83.3%。     

中药制剂防治肉鸡肾性传染性支气管炎的实验研究

将某养殖场已确诊为肾性传染性支气管炎的25日龄肉鸡300只，随机分为6组，应用研制的复方中药制剂——禽速康口服液按不同剂量组合进行治疗试验。结果表明，禽速康(3mL／kg)与肾舒宝(40mg／kg)联合疗法，对内鸡肾性传染性支气管炎有较好的疗效，用药3d可控制发病鸡死亡，治愈率达82％。经大群推广试验表明，禽速康与肾舒宝联合防治肉鸡肾性传染性支气管炎，效果确实，防治有效率达93．75％。     

羊草种子萌发相关基因的筛选及表达分析

前期实验表明,变温处理(28 ℃ 12 h/16 ℃ 12 h)可显著提高羊草种子的萌发率,且羊草种子萌发中的第1天是接受变温信号的关键时期。以此为研究基础,结合羊草种子变温萌发的转录组测序数据,针对羊草种子萌发初期对变温处理的响应筛选出与种子萌发、休眠及低温相关的基因24个,利用测序结果中这些基因的RPKM值制作基因表达热图并分析其表达差异。以萌发率高、低的两种羊草种质的种子为材料,对24个基因在恒温12 h(28 ℃)和变温1 d(28 ℃ 12 h/16 ℃ 12 h)萌发处理中的表达分别进行了定量分析。结果表明,与恒温对照相比,变温处理12 h后,表达明显上调的基因有SAIN1,PP2C62,EXPB3,EXPB4,GA3ox,EXPA2和EXPA7,而表达明显下调的基因有bHLH49,GID1,ABI8,Chi1,11833,CBF3,NAC2,PP2C72,SAIN2和5423。通过进一步分析相关基因在高、低萌发率两个种质中表达的差异,筛选出其中可能与羊草种子萌发相关的基因有几丁质酶基因Chi1,转录因子基因CBF3,羊草新基因5423,赤霉素合成基因GA3ox,细胞松弛素蛋白基因EXPB4和羊草新基因SAIN1,将为下一步阐明羊草种子萌发的分子作用机理奠定基础。     

Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild‐to‐moderate clinical mastitis in dairy cows with longer lasting udder diseases

A nonblinded, positively controlled, noninferiority trial was conducted to evaluate the efficacy of an alternative, nonantibiotic therapy with Masti Veyxym^® to reduce ineffective antibiotic usage in the treatment of nonsevere clinical mastitis (CM) in cows with longer lasting udder diseases. The solely intramammary treatment with Masti Veyxym^® (three applications, 12 hr apart) and the combined treatment with Masti Veyxym^® and antibiotics as usual on the farm according to label of the respective product were compared with the reference treatment of solely antibiotic therapy. The matched field study was conducted on eight free‐stall dairy farms located in Eastern Germany. Cases of mild‐to‐moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation were randomly allocated to one of the three treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 14 days and 21 days after the end of therapy for cyto‐bacteriological examination. Primary outcomes were clinical cure (CC) and no CM recurrence within 60 days after the end of treatment (no R60). Bacteriological cure (BC) and quarter somatic cell count (QSCC) cure were chosen as secondary outcomes although low probabilities of BC and QSCC cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Streptococcus uberis, followed by Staphylococcus aureus and coagulase‐negative staphylococci. There were no significant differences between the two test treatments in comparison with the reference treatment regarding all outcome variables. The sole therapy with Masti Veyxym^® resulted in a numerically lower likelihood of BC without significant differences to the reference treatment. The combined therapy group showed a numerically higher nonrecurrence rate than the two other treatment groups and noninferiority compared to the reference treatment was proven. Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Masti Veyxym^® in nonsevere CM cases may constitute an alternative therapy to reduce antibiotics. However, noninferiority evaluations were mostly inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a clear statement on noninferiority.     

大型综合医院户外空间植物景观研究

为营造良好的医院户外空间,采用文献查阅和综合分析等方法对广州市3家大型综合医院的绿地植物景观进行研究。结果表明:3家医院共有植物116种,其中骨干树种和基调树种的重复率较高,乔灌比值偏小,常绿与落叶比相对合理,色彩应用设计合理。在交往空间的搭配中,广东省中医院的交往空间最丰富,广东省人民医院私密型空间较少,中山大学第一附属医院对病人户外交往空间考虑不够,空间应用的元素较为单一。     

碳纳米管的酸化处理对碳纳米管/聚氨酯复合材料微观结构及性能的影响

对多壁碳纳米管进行酸化处理,并采用原位聚合法制备了碳纳米管/聚氨酯复合材料。利用X射线光电子能谱分析(XPS)、电子扫描显微镜(SEM)、动态力学分析(DMA)研究了碳纳米管酸化与否对复合材料性能的影响。结果表明,碳纳米管经酸化处理后产生了羧基,碳纳米管的原位加入使得复合材料的储存模量和玻璃化转变温度都有所提高,而且经过酸化的碳纳米管对聚氨酯材料的改性要比未酸化碳纳米管对聚氨酯材料的改性效果更为显著。     

不同外植体及冷藏处理对华中枸骨组织培养的影响

[目的]研究不同外植体及冷藏处理对华中枸骨组织培养的影响。[方法]以华中枸骨带芽新梢茎段为外植体,考察外植体的取材时间、部位以及4℃冷藏处理对其初代培养的影响。[结果]华中枸骨以带芽的新梢茎段作为外植体进行组织培养时,以春季采取植株中上部枝条为宜,其中春季萌条的芽增殖倍数可达到4,中上部萌条的芽萌动率可达到45%。适当的冷藏处理对外植体的消毒以及芽的萌动有利,4℃冷藏处理14 h后的消毒成功率最高,可达到92%;冷藏处理22 h的芽萌动率最高,可达到18%。[结论]华中枸骨组织培养中外植体最好于春季选取植株中上部萌发的新梢顶芽;华中枸骨芽的萌动率随冷藏时间的增加呈线性增长,可能与低温打破休眠有关。     

利用废弃浸渍纸制造刨花板的试验研究

利用废弃浸渍纸粉末替代部分脲醛树脂胶压制刨花板,采用正交试验方案并考察刨花板的主要理化性能,探讨浸渍纸粉末部分或全部替代脲醛胶的可行性。结果表明:废弃浸渍纸粉末用量为20%、脲醛树脂用量为5%、热压温度为190℃、热压时间为0.4 min/mm时,所压制的刨花板静曲强度为17.97 MPa,内结合强度为0.76 MPa,甲醛释放量为5.69 mg/100g,废弃浸渍纸粉末可部分替代脲醛树脂压制刨花板且性能较佳。